Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

Grade Last Price % Change Price Change
grade B 4.07 -1.69% -0.07
CPRX closed down 1.9 percent on Thursday, July 18, 2019, on 49 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical CPRX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.69%
Inside Day Range Contraction -1.69%
Overbought Stochastic Strength -1.69%
Reversal New Highs Setup Bullish Swing Setup -3.55%
Stochastic Reached Overbought Strength -3.55%
Outside Day Range Expansion -3.55%
Overbought Stochastic Strength -3.55%
Up 3 Days in a Row Strength -3.55%
Narrow Range Bar Range Contraction -0.73%
NR7 Range Contraction -0.73%

Older signals for CPRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Health Pharmaceutical Pharmaceutical Industry California Medication Disorders Virotherapy Health Sciences Epilepsy Pharmaceutical Sciences Biomarin Pharmaceutical Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Novato Tourette Syndrome Treatment Of Epilepsy
Is CPRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.16
52 Week Low 1.85
Average Volume 2,257,440
200-Day Moving Average 3.423
50-Day Moving Average 3.6676
20-Day Moving Average 3.928
10-Day Moving Average 4.084
Average True Range 0.2147
ADX 20.61
+DI 25.2678
-DI 11.9919
Chandelier Exit (Long, 3 ATRs ) 3.6459
Chandelier Exit (Short, 3 ATRs ) 4.1241
Upper Bollinger Band 4.3287
Lower Bollinger Band 3.5273
Percent B (%b) 0.76
BandWidth 20.40224
MACD Line 0.1038
MACD Signal Line 0.0762
MACD Histogram 0.0276
Fundamentals Value
Market Cap 350.05 Million
Num Shares 84.6 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -20.70
Price-to-Sales 0.00
Price-to-Book 6.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.44
Resistance 3 (R3) 4.45 4.37 4.39
Resistance 2 (R2) 4.37 4.29 4.36 4.37
Resistance 1 (R1) 4.25 4.24 4.21 4.24 4.36
Pivot Point 4.17 4.17 4.15 4.16 4.17
Support 1 (S1) 4.05 4.09 4.01 4.04 3.92
Support 2 (S2) 3.97 4.04 3.96 3.91
Support 3 (S3) 3.85 3.97 3.89
Support 4 (S4) 3.84